Media Reports on Michael Nelson, MD, PhD’s Work on an FDA Committee

June 8, 2022 by

Asthma, Allergy and Immunology Division Chief Michael Nelson was one of the vaccine advisers to the US Food and Drug Administration who decided  that authorizing Novavax’s Covid-19 vaccine – which uses different technology from the three vaccines currently in use in the US – for emergency use in adults would be beneficial.

Read the story on CNN.

Filed Under: Media Highlights, Research